Lamminmäki U - Search Results

1

Generation and characterization of a single-chain anti-EphA2 antibody.

Goldgur Y, Susi P, Karelehto E, Sanmark H, Lamminmäki U, Oricchio E, Wendel HG, Nikolov DB, Himanen JP. Goldgur Y, et al. Among authors: lamminmaki u. Growth Factors. 2014 Dec;32(6):214-22. doi: 10.3109/08977194.2014.983225. Epub 2014 Nov 19. Growth Factors. 2014. PMID: 25494541 Free PMC article.

2

Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease.

Negi P, Heikkilä T, Vuorenpää K, Tuunainen E, Nammas W, Maaniitty T, Knuuti J, Metso J, Lövgren J, Jauhiainen M, Lamminmäki U, Pettersson K, Saraste A. Negi P, et al. Among authors: lamminmaki u. Front Cardiovasc Med. 2022 Oct 14;9:912578. doi: 10.3389/fcvm.2022.912578. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36312264 Free PMC article.

3

ImmunoPET Directed to the Brain: A New Tool for Preclinical and Clinical Neuroscience.

de Lucas ÁG, Lamminmäki U, López-Picón FR. de Lucas ÁG, et al. Among authors: lamminmaki u. Biomolecules. 2023 Jan 13;13(1):164. doi: 10.3390/biom13010164. Biomolecules. 2023. PMID: 36671549 Free PMC article. Review.

4

Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform.

Huhtinen O, Salbo R, Lamminmäki U, Prince S. Huhtinen O, et al. Among authors: lamminmaki u. Front Bioeng Biotechnol. 2023 May 9;11:1170081. doi: 10.3389/fbioe.2023.1170081. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37229492 Free PMC article.

5

Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects.

Oksanen S, Saarinen R, Korkiakoski A, Lamminmäki U, Huovinen T. Oksanen S, et al. Among authors: lamminmaki u. Sci Rep. 2023 Aug 11;13(1):13107. doi: 10.1038/s41598-023-40241-2. Sci Rep. 2023. PMID: 37567990 Free PMC article.

6

Oligovalent Fab display on M13 phage improved by directed evolution.

Huovinen T, Sanmark H, Ylä-Pelto J, Vehniäinen M, Lamminmäki U. Huovinen T, et al. Among authors: lamminmaki u. Mol Biotechnol. 2010 Mar;44(3):221-31. doi: 10.1007/s12033-009-9231-3. Mol Biotechnol. 2010. PMID: 20012710

7

Enhanced error-prone RCA mutagenesis by concatemer resolution.

Huovinen T, Julin M, Sanmark H, Lamminmäki U. Huovinen T, et al. Among authors: lamminmaki u. Plasmid. 2011 Oct;66(1):47-51. doi: 10.1016/j.plasmid.2011.03.004. Epub 2011 Mar 29. Plasmid. 2011. PMID: 21453722

8

Two ScFv antibody libraries derived from identical VL-VH framework with different binding site designs display distinct binding profiles.

Huovinen T, Syrjänpää M, Sanmark H, Brockmann EC, Azhayev A, Wang Q, Vehniäinen M, Lamminmäki U. Huovinen T, et al. Among authors: lamminmaki u. Protein Eng Des Sel. 2013 Oct;26(10):683-93. doi: 10.1093/protein/gzt037. Epub 2013 Aug 21. Protein Eng Des Sel. 2013. PMID: 23966567

9

The selection performance of an antibody library displayed on filamentous phage coat proteins p9, p3 and truncated p3.

Huovinen T, Syrjänpää M, Sanmark H, Seppä T, Akter S, Khan LM, Lamminmäki U. Huovinen T, et al. Among authors: lamminmaki u. BMC Res Notes. 2014 Sep 19;7:661. doi: 10.1186/1756-0500-7-661. BMC Res Notes. 2014. PMID: 25238965 Free PMC article.

10

Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.

Lamminmaki U, Nikolov D, Himanen J. Lamminmaki U, et al. Curr Drug Targets. 2015;16(10):1021-30. doi: 10.2174/1389450116666150531154619. Curr Drug Targets. 2015. PMID: 26028047 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page